Saba Capital sells ECAT shares, keeps 25.47M
Saba Capital Management, L.P., a 10% owner of BlackRock ESG Capital Allocation Term Trust (ECAT), reported selling common shares in two transactions.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Saba Capital Management, L.P., a 10% owner of BlackRock ESG Capital Allocation Term Trust (ECAT), reported selling common shares in two transactions. On January 27, 2026, it sold 83,984 shares at $15.54 per share. On January 28, 2026, it sold a further 105,896 shares at $15.53 per share. After these sales, Saba Capital Management, L.P. reported 25,470,310 ECAT shares beneficially owned indirectly.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 105,896 | $15.53 | $1.64M |
| Sale | Common Stock | 83,984 | $15.54 | $1.31M |
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider activity did Saba Capital Management report for ECAT?
What is Saba Capital Management’s relationship to BlackRock ESG Capital Allocation Term Trust (ECAT)?
Were there any derivative securities involved in Saba Capital’s ECAT Form 4 filing?
Are Saba Capital’s ECAT holdings reported as direct or indirect ownership?
AI-generated analysis. How Rhea-AI works. Not financial advice.